| Capital Markets Industry | Financials Sector | - CEO | MSE Exchange | INE01GR01018 ISIN |
| Israel Country | - Employees | 16 Mar 2022 Last Dividend | - Last Split | - IPO Date |
Hive 2040 R&D Limited Partnership is a forward-looking entity that operates primarily within the venture capital (VC) sector, with a specific focus on research and development (R&D). Based in Israel, a hub for technological innovation and startup culture, Hive 2040 positions itself at the confluence of investment and innovation, aiming to nurture and accelerate the growth of groundbreaking technologies. The company is carved out as a unique player in the VC landscape, emphasizing the developmental stages of startups, where research plays a critical factor in future success.
Hive 2040 provides crucial early-stage funding dedicated to the research phase of startups. This pivotal support is targeted at companies with promising innovative technologies that require capital to refine and develop their products or services. By investing in research, Hive 2040 ensures that these early ventures have the resources needed to advance their projects to stages where they can attract further investment or reach market readiness.
Beyond financial assistance, Hive 2040 offers developmental support services designed to guide startups through the complexities of the R&D process. This includes access to a network of industry experts, mentorship programs, and strategic planning resources. The aim is to not only provide financial backing but also to equip startups with the expertise and guidance they need to navigate the challenging early stages of development successfully.
Recognizing the importance of collaboration in the innovation ecosystem, Hive 2040 actively facilitates partnership opportunities between its portfolio companies and leading industry players. These partnerships often lead to co-development projects, enhanced market entry strategies, and even joint ventures, all geared towards accelerating the path from research to commercialization.